Home BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation
 

Keywords :   


BIO Joins AdvaMed, PhRMA in Letter Expressing Concerns with Sunshine Act Implementation

2014-09-22 06:00:00| Industrial Newsroom - All News for Today

BIO President and CEO James Greenwood joined AdvaMed President and CEO Stephen Ubl and PhRMA President and CEO John Castellani in letter to CMS Administrator Marilyn Tavenner highlighting ongoing concerns about potential lack of necessary context around Sunshine data release. Physician Payments Sunshine Act, section 6002 of Affordable Care Act of 2010, will provide transparency in industry collaboration with teaching hospitals, physicians; and report physician ownership and investment ...This story is related to the following:Trade Associations

Tags: act letter concerns implementation

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
23.11 BUG ! TOO !
23.11BTS 10 FESTA ARMY JUNGKOOK
23.11 SAO 2015
23.1178580g
23.112
23.1170
23.11 BOX
23.11
More »